Yves Bikorimana։ Normal MCV Doesn’t Always Mean Normal RBCs
Yves Bikorimana, CEO at MedData – Rwanda and Lab Scientist at The University Teaching Hospital of Kigali – Chuk, shared a post on LinkedIn:
”A normal Mean Corpuscular Volume (MCV) does not always mean the red blood cells are actually normal in size.
What’s happening here?
MCV measures the average size of red blood cells (RBCs).
In the image:
- One side has small cells (microcytes)
- The other side has large cells (macrocytes)
When you average them together, the result can appear ‘normal’
So the lab value says ‘normal MCV,’ but in reality, there is a mixed population of abnormal cells.
This phenomenon is called:
Anisocytosis: meaning variation in red blood cell sizes.
Why does this matter clinically?
A normal MCV can hide underlying disease, such as:
- Combined deficiencies:
Iron deficiency – small cells
Vitamin B12 or folate deficiency – large cells
- Recent blood transfusion (mix of donor and patient cells)
- Certain bone marrow disorders
How do we detect the ‘different reality’?
We don’t rely on MCV alone. We also look at:
- Red Cell Distribution Width (RDW)
Measures variation in RBC size
High RDW = mixed population (like in the image)
- Peripheral blood smear
Directly shows the mix of small and large cells
Key takeaway:
- A normal average (MCV) can be misleading.
- Always interpret it alongside RDW and blood smear findings.”
Stay updated with Hemostasis Today.
-
Jun 7, 2026, 06:57Chandran Nadarajan: Targeted Endovascular Thrombolysis Offers Organ-Saving Benefits in Vascular Occlusions
-
Jun 7, 2026, 05:50Sayan Koley: Lupus Anticoagulant – A Key Marker in Thrombosis Risk Assessment
-
Jun 7, 2026, 05:45Nicolas Hubacz: Watching a Heart Build Its Network
-
Jun 7, 2026, 05:40New Evidence Highlights the Urgent Need for Gender-Inclusive Bleeding Disorders Research – EHC
-
Jun 7, 2026, 03:15Shirley D’Sa: What Comes After BTK Inhibitors in Waldenström Macroglobulinaemia?
-
Jun 6, 2026, 23:30Yazan Abou-Ismail: Insights on A Snail-Derived Potential Anticoagulant with Possibly Improved Bleeding Profile
-
Jun 6, 2026, 18:40Igor Carvalho de Oliveira: The Hidden Genetic Risk Behind Early Heart Attacks and Strokes
-
Jun 6, 2026, 17:39Kalyan Roy: Immunomodulation after Blood Transfusion
-
Jun 6, 2026, 17:37Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?